US 11248039
Immunoglobulin single variable domain antibody against RSV prefusion F protein
granted A61KA61K2039/505A61K2039/55561
Quick answer
US patent 11248039 (Immunoglobulin single variable domain antibody against RSV prefusion F protein) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2039/55561, A61K39/12, A61P